Group 1 - Shenzhen Precision Medical Technology Co., Ltd. (stock code: 02675.HK) officially listed on the Hong Kong Stock Exchange, becoming the first company in Shenzhen to complete an IPO in the new year, with an issue price of HKD 43.24 and a subscription rate of 1,091.94 times, opening at HKD 59, a significant increase of 36.45% from the issue price, with a market capitalization exceeding HKD 20 billion [1][3] - The successful listing marks a new phase for the company characterized by globalization and scaling, following breakthroughs in core technology and commercialization [3] - The company has developed a complete product layout covering multi-port, single-port, and natural orifice surgical robots, being the first in China and the second globally to commercialize both multi-port and single-port laparoscopic surgical robots [3] Group 2 - The company's operational performance has rapidly improved, with projected revenue of CNY 149 million for the first half of 2025, nearly quadrupling compared to the same period in 2024, and a gross margin of approximately 62.8%, indicating high commercialization quality and sustainability [5] - As of the latest available date, over 12,000 robotic-assisted surgeries have been completed using the multi-port laparoscopic surgical robot, and over 2,000 surgeries with the single-port laparoscopic surgical robot, showing a stable increase in clinical usage [5] - The company was co-founded by PhDs from MIT and Harvard, with strategic shareholders including well-known institutions such as the Social Security Fund, Sequoia China, and Kangji Medical [7] Group 3 - The IPO attracted 14 top international institutions as cornerstone investors, collectively subscribing for USD 75 million, reflecting strong international long-term capital recognition of the Chinese surgical robot industry and the company's technology and business model [8] - The company aims to leverage its Hong Kong listing to focus on core technology innovation in surgical robots, expand product application scenarios, and enhance global market coverage, promoting domestic high-end medical equipment on the world stage [8] - Longgang District has nurtured 50 listed companies domestically and internationally, supported by a comprehensive service system and a full-chain service support mechanism for enterprises at different development stages [9]
精锋医疗在香港上市 为新年深圳首家完成IPO企业